ASA Newsletter

For the Professional in Government, Industry and Academia with an interest in Nuclear, Biological and Chemical Defense, Disarmament and Verification; Chemical and Biological Terrorism; Emergency and Disaster Medical Planning; Industrial Health and Safety; and Environmental Protection.

ASA 04-3, Issue No. 102, June 24, 2004


The following is a draft version of the opening remarks by King Karl XVI Gustaf. The King actually made the speech a bit longer and also a bit more personal, referring to the great interest the Crown Princess Victoria has in these issues.

The Opening Remarks By His Majesty King Carl XVI Gustaf

At the Eighth International Symposium on Protection Against Chemical and Biological Warfare Agents

Excellencies,
Ladies and Gentlemen,

I have had the pleasure of opening this symposium a couple of times before. In my opening speech at the sixth symposium, six years ago, I emphasized the political changes in the world that had taken place during the first part of the nineties, with implications on the threat picture from biological and chemical warfare agents.

Full Article

21 Years Of CBW Protection: A Changing World

By Graham S. Pearson
Visiting Professor in International Security
Department of Peace Studies,
University of Bradford, West Yorkshire UK

Introduction
          The occasion of 21 years of the Swedish Symposiums on Protection against Chemical and Biological Warfare Agents provides an opportunity to consider the changing world and how the perceptions of the threat posed by chemical and biological weapons have developed.

Full Article

Dr. DeBell is a well-known world authority within this complex area and ASA is very pleased to present his CBMTS V paper for the ASA family of professionals.

Progress in Research with the plcR Gene in Bacillus anthracis

Robert M. DeBell, Ph.D.
Battelle Memorial Institute

Introduction
          Ongoing research with Bacillus anthracis is attempting to expand our understanding of the spectrum of genomic capabilities to include the expression of new virulence factors. Although these studies are academic and valuable from a microbiology perspective, there are concerns in that they demonstrate genetic alterations that could change the pathogenicity of B. anthracis. Knowledge of this work is most important to ensure that anthrax therapies are adequate to treat anthrax or that competent therapies be developed to avoid circumvention by a genetically altered form of B. anthracis.

 

Full Article

an inside look at ASA 04-3

The Professional Library
2
4th SISPAT / CBMTS
3
CBMTS V: A report and pictures
8
8th Int’l Sym. on Protection Against CBW 10
A letter from Uzbekistan 14
ON THE STREET 15
FOCAL POINT NEWS 15
Long Term PsychoSocial Impact of CW 19
NBC Books in Japan 22
The JMCD 26
GAO Reports 27
Industry Notes 27
Recent Contracts 29
BioScope 04 32

 

 
Next

For the Professional in Government and Industry with an interest in Nuclear, Biological and Chemical Defense, Disarmament and Verification; Emergency and Disaster Medical Planning; Industrial Health and Safety; and Environmental Protection


copyright©2004, ASA Inc. All rights reserved.